Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Jun;11(6):794-801.
doi: 10.3201/eid1106.050167.

Antimicrobial resistance determinants and future control

Affiliations
Review

Antimicrobial resistance determinants and future control

Stephan Harbarth et al. Emerg Infect Dis. 2005 Jun.

Abstract

At the beginning of the 21st century, antimicrobial resistance is common, has developed against every class of antimicrobial drug, and appears to be spreading into new clinical niches. We describe determinants likely to influence the future epidemiology and health impact of antimicrobial-resistant infections. Understanding these factors will ultimately optimize preventive strategies for an unpredictable future.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Posters from nationwide educational campaigns against misuse of antimicrobial drugs.
Figure 2
Figure 2
Number of antimicrobial drug packages sold in the outpatient setting in Chile, 1988–2002. Package is the term used to show sales figures of antimicrobial drugs from wholesalers or pharmacies. It is also used to calculate the number of daily defined doses for each marketed antimicrobial drug. Data are from Bavestrello et al (32). Unpublished data from 2001 and 2002 were provided by A. Cabello Munoz and L. Bavestrello (Viña del Mar, Chile).

References

    1. Livermore D. Can better prescribing turn the tide of resistance? Nat Rev Microbiol. 2004;2:73–8. 10.1038/nrmicro798 - DOI - PubMed
    1. Weber JT, Courvalin P. An emptying quiver: antimicrobial drugs and resistance. Emerg Infect Dis. 2005;11:791–3. 10.3201/eid1106.050471 - DOI - PMC - PubMed
    1. Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr Opin Microbiol. 1999;2:489–93. 10.1016/S1369-5274(99)00005-3 - DOI - PubMed
    1. Harbarth S, Albrich W, Goldmann DA, Huebner J. Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis. 2001;1:251–61. 10.1016/S1473-3099(01)00120-7 - DOI - PubMed
    1. Nuermberger EL, Bishai WR. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold? Clin Infect Dis. 2004;38(Suppl 4):S363–71. 10.1086/382696 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources